Cord blood stem cells tested in stroke patients – early safety check

NCT ID NCT03186456

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether stem cells from donated umbilical cords are safe for people who recently had a stroke. Forty participants will receive three monthly infusions of the cells along with standard aspirin therapy. The study is currently on hold, and its main goal is to monitor for side effects, not to prove the treatment works.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

human umbilical cord-derived mesenchymal stem cells

What this could lead to

If it works, this could point toward a new way to help people recover from stroke by reducing brain damage.

What could go wrong

This is a very early, small trial (Phase 1, 40 people) that is currently suspended. It only tests safety, not whether it truly works, and stem cell treatments carry risks like infection or immune reactions.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL INFARCTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Inner Mongolia International Mongolian Hospital

    Hohhot, Inner Mongolia, 010065, China